ASCO chooses R.I. hospital as breast cancer registry pilot site

The Miriam Hospital in Providence, R.I., has been selected by American Society for Clinical Oncology (ASCO) to be included in its national Breast Cancer Registry Pilot Program.

One of the 20 sites, the provider will be included in a registry that can be used for practice-based quality improvement of data collection, improved communication and care coordination for patients with breast cancer, said ASCO.

The hospital will collect and enter data on newly diagnosed patients with Stage 0-III breast cancer for 18 months using ASCO’s Web-based template, which will allow physicians to generate patient-specific breast cancer treatment plans. The physicians then will take part in a research study that will determine the effectiveness of the pilot program.

The two-year pilot program is funded by Susan G. Komen for the Cure, a research group that explores causes, treatment and the search for a cure to breast cancer, said the Dallas-based group

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.